ACHILLION PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - March 11, 2010

Attached files

file filename
10-K - FORM 10-K - ACHILLION PHARMACEUTICALS INCd10k.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ACHILLION PHARMACEUTICALS INCdex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ACHILLION PHARMACEUTICALS INCdex311.htm
EX-10.5 - AMENDED AND RESTATED LICENSE AGREEMENT - ACHILLION PHARMACEUTICALS INCdex105.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906 - ACHILLION PHARMACEUTICALS INCdex321.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ACHILLION PHARMACEUTICALS INCdex322.htm
EX-10.26 - 2006 STOCK INCENTIVE PLAN AS AMENDED SEPTEMBER 18, 2006 AND MARCH 9, 2010 - ACHILLION PHARMACEUTICALS INCdex1026.htm
EX-10.10 - SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT - MILIND DESPHANDE - ACHILLION PHARMACEUTICALS INCdex1010.htm
EX-10.12 - SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT - MARY KAY FENTON - ACHILLION PHARMACEUTICALS INCdex1012.htm
EX-10.32 - 2006 EMPLOYEE STOCK PURCHASE PLAN AS AMENDED SEPTEMBER 18, 2006 - ACHILLION PHARMACEUTICALS INCdex1032.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-149729,333-141661, 333-138984, and 333-158241) and Form S-3 (Nos. 333-153870 and 333-162306) of Achillion Pharmaceuticals, Inc. of our report dated March 11, 2010 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

PricewaterhouseCoopers LLP

March 11, 2010

Hartford, Connecticut

ACHILLION PHARMACEUTICALS INC Reports